Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-18

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating whether sequential treatment with Clevudine and Peg-interferon improves efficacy and safety compared with Clevudine alone in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clevudine (clevudine)
  • Peg-interferon (pegylated interferon alfa)

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: HBeAg(+) Chronic Hepatitis B | Phase 4 | Status: COMPLETED